The report provides a detailed analysis essential for establishing a Metoclopramide (Reglan) production plant. It encompasses all critical aspects necessary for Metoclopramide (Reglan) production, including the cost of Metoclopramide (Reglan) production, Metoclopramide (Reglan) plant cost, Metoclopramide (Reglan) production costs, and the overall Metoclopramide (Reglan) production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Metoclopramide (Reglan) production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Metoclopramide (Reglan) is a type of medication that is widely utilized for the treatment of symptoms of gastroesophageal reflux disease (GERD). Moreover, it is often used to relieve heartburn, nausea, vomiting, etc., by promoting gastric motility. Additionally, this drug is also employed in reducing the duration of labor during childbirth. It also finds its application in the treatment of gastroparesis in diabetes patients and in preventing nausea induced by certain surgeries.
The market for Metoclopramide (Reglan) is majorly led by its wide usage as an antiemetic and gastrointestinal motility agent for addressing stomach and oesophageal issues, which significantly promotes its demand in the medical and pharmaceutical industries. Moreover, its utilization in reducing the duration of labor and increasing the probability of faster delivery in pregnant women further enhances its demand in the medical industry.
Additionally, its employment in the treatment and prevention of vomiting and nausea by enhancing proper gastric movements further boosts its market expansion. Furthermore, several factors influence industrial Metoclopramide (Reglan) procurement, such as the cost and availability of its raw materials (N, N-diethylethylenediamine, etc.), cost and pricing, compliance with medical regulations, quality standards, technological advancements, environmental considerations, sustainability practices, distribution (including trading and shipping), logistics, safety standards, etc.
Raw Material for Metoclopramide (Reglan) Production
According to the Metoclopramide (Reglan) production plant project report, the major raw materials for Metoclopramide (Reglan) production include N, N-diethylethylenediamine - 4-Acetamido-5-chloro-2-methoxybenzoyl chloride.
Production Process of Metoclopramide (Reglan)
The extensive Metoclopramide (Reglan) production cost report consists of the following industrial production process:
- Production via Condensation: This production process involves the chemical reaction of N, N-diethylethylenediamine with 4-acetamido-5-chloro-2-methoxybenzoyl chloride, which results in the formation of Metoclopramide as the final product. This reaction involves a nucleophilic substitution process in which Thethe amine group of N, N-diethylethylenediamine replaces the chloride ion from the acyl chloride to facilitate the production of Metoclopramide.
Metoclopramide (Reglan) is a form of medicine that belongs to the class of prokinetic agents. It is available in various formulations, which include oral solution, tablet, and injection form. Storage conditions for this drug require a temperature between 20-25 degrees Celsius. The molecular formula of the compound is C14H22ClN3O2, and its molar mass is 299.79 g/mol. It is a derivative of para-aminobenzoic acid (PABA). The molar mass of the compound is 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide. The melting point of the compound is 147.25 °C, and its boiling point is 418.7°C. Its crystal form decomposes at 145 degrees Celsius. When metoclopramide hydrochloride is exposed to light, it breaks down due to photosensitivity.